TY  - GEN
AU  - Yang,Chang
AU  - Davis,Jennifer L
AU  - Zeng,Rong
AU  - Vora,Paras
AU  - Su,Xinming
AU  - Collins,Lynne I
AU  - Vangveravong,Suwanna
AU  - Mach,Robert H
AU  - Piwnica-Worms,David
AU  - Weilbaecher,Katherine N
AU  - Faccio,Roberta
AU  - Novack,Deborah Veis
TI  - Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation
SN  - 2159-8290
PY  - 2013///0820
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Bone Density Conservation Agents
KW  - adverse effects
KW  - Bone Neoplasms
KW  - metabolism
KW  - Bone and Bones
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cells, Cultured
KW  - Diphosphonates
KW  - administration & dosage
KW  - Humans
KW  - Imidazoles
KW  - Inhibitor of Apoptosis Proteins
KW  - antagonists & inhibitors
KW  - Macrophages
KW  - cytology
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Inbred C57BL
KW  - Mice, Nude
KW  - Molecular Structure
KW  - Oligopeptides
KW  - Osteoclasts
KW  - Osteoporosis
KW  - chemically induced
KW  - Xenograft Model Antitumor Assays
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/2159-8290.CD-12-0271
ER  -